Tag: Moleculin stock

Moleculin Biotech, Inc. (MBRX) stock is rising today: What’s Going on?

MTTR

Moleculin Biotech, Inc. (MBRX) announced today that it has been granted Rare Pediatric Disease Designation (RPD) for WP1066 to treat ependymoma after which the MBRX stock price saw an uptrend of 7.18% to reach $4.16 a share at the time of this writing. MBRX stock was also green in the previous trading session and went […]

Get your daily dose of news with exclusive content, articles, and more at The Market Globalist, a free online newspaper launched in May 2010. They’re young, but ambitious, aiming to deliver engaging and informative content. Contribute your own stories and photos to be part of the community!

Quick Links

Categories

Copyright © 2024 Market Globalist , All rights reserved.

Market Globalist
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.